Respiratory syncytial virus, RSV
GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...
We are stronger when we are all protected against respiratory diseases,” said Dr. Tomas Aragon, public health officer for ...
The arrival of cooler weather and people gathering indoors can lead to the increased spread of COVID-19, influenza and ...
(RSV) is a common cause of lower respiratory tract infection (LRTI) and is responsible for a high burden of hospital admission and mortality in children. RSV–LRTI is also associated with long-term ...
The new, free vaccine, Beyfortus, will be available to children up to 24 months old through their health care provider or at ...
reactogenicity and safety of Arexvy (Respiratory Syncytial Virus Vaccine) when co-administered with Shingrix (Zoster Vaccine). Shingrix is approved to prevent shingles (herpes zoster) in adults ...